Savi P - Search Results

1

Revascularization of ischemic tissues by PDGF-CC via effects on endothelial cells and their progenitors.

Li X, Tjwa M, Moons L, Fons P, Noel A, Ny A, Zhou JM, Lennartsson J, Li H, Luttun A, Pontén A, Devy L, Bouché A, Oh H, Manderveld A, Blacher S, Communi D, Savi P, Bono F, Dewerchin M, Foidart JM, Autiero M, Herbert JM, Collen D, Heldin CH, Eriksson U, Carmeliet P. Li X, et al. Among authors: savi p. J Clin Invest. 2005 Jan;115(1):118-27. doi: 10.1172/JCI19189. J Clin Invest. 2005. PMID: 15630451 Free PMC article.

2

Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy.

Angelillo-Scherrer A, Burnier L, Flores N, Savi P, DeMol M, Schaeffer P, Herbert JM, Lemke G, Goff SP, Matsushima GK, Earp HS, Vesin C, Hoylaerts MF, Plaisance S, Collen D, Conway EM, Wehrle-Haller B, Carmeliet P. Angelillo-Scherrer A, et al. Among authors: savi p. J Clin Invest. 2005 Feb;115(2):237-46. doi: 10.1172/JCI22079. J Clin Invest. 2005. PMID: 15650770 Free PMC article.

3

Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration.

Favier B, Alam A, Barron P, Bonnin J, Laboudie P, Fons P, Mandron M, Herault JP, Neufeld G, Savi P, Herbert JM, Bono F. Favier B, et al. Among authors: savi p. Blood. 2006 Aug 15;108(4):1243-50. doi: 10.1182/blood-2005-11-4447. Epub 2006 Apr 18. Blood. 2006. PMID: 16621967 Free article.

4

Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis.

Angelillo-Scherrer A, de Frutos P, Aparicio C, Melis E, Savi P, Lupu F, Arnout J, Dewerchin M, Hoylaerts M, Herbert J, Collen D, Dahlbäck B, Carmeliet P. Angelillo-Scherrer A, et al. Among authors: savi p. Nat Med. 2001 Feb;7(2):215-21. doi: 10.1038/84667. Nat Med. 2001. PMID: 11175853

5

Heterodimerization with vascular endothelial growth factor receptor-2 (VEGFR-2) is necessary for VEGFR-3 activity.

Alam A, Herault JP, Barron P, Favier B, Fons P, Delesque-Touchard N, Senegas I, Laboudie P, Bonnin J, Cassan C, Savi P, Ruggeri B, Carmeliet P, Bono F, Herbert JM. Alam A, et al. Among authors: savi p. Biochem Biophys Res Commun. 2004 Nov 12;324(2):909-15. doi: 10.1016/j.bbrc.2004.08.237. Biochem Biophys Res Commun. 2004. PMID: 15474514

6

The mitogenic effect of H2O2 for vascular smooth muscle cells is mediated by an increase of the affinity of basic fibroblast growth factor for its receptor.

Herbert JM, Bono F, Savi P. Herbert JM, et al. Among authors: savi p. FEBS Lett. 1996 Oct 14;395(1):43-7. doi: 10.1016/0014-5793(96)00998-2. FEBS Lett. 1996. PMID: 8849686 Free article.

7

Non-specific inhibition of ADP-induced platelet antiaggregation by clopidogrel in vitro.

Herbert JM, Savi P. Herbert JM, et al. Among authors: savi p. Thromb Haemost. 1999 Jul;82(1):156-7. Thromb Haemost. 1999. PMID: 10456476 No abstract available.

8

P2Y12, a new platelet ADP receptor, target of clopidogrel.

Herbert JM, Savi P. Herbert JM, et al. Among authors: savi p. Semin Vasc Med. 2003 May;3(2):113-22. doi: 10.1055/s-2003-40669. Semin Vasc Med. 2003. PMID: 15199474 Review.

9

Use of radiolabeled 2-methylthio-ADP to study P2Y receptors on platelets and cell lines.

Savi P, Herbert JM. Savi P, et al. Methods Mol Biol. 2004;273:115-24. doi: 10.1385/1-59259-783-1:115. Methods Mol Biol. 2004. PMID: 15308797 No abstract available.

10

Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis.

Savi P, Herbert JM. Savi P, et al. Semin Thromb Hemost. 2005 Apr;31(2):174-83. doi: 10.1055/s-2005-869523. Semin Thromb Hemost. 2005. PMID: 15852221 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters